NCT02861417 2026-02-17Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Active not recruiting204 enrolled
NCT03162536 2025-09-08ARQ 531-101ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1/2 Active not recruiting190 enrolled